Skip to main content

Table 1 Characteristics of pregnant women by SARS-CoV-2 infection status. The Georgian Birth Registry, February 28, 2020- August 30, 2022

From: SARS-CoV-2 infection during pregnancy and the risk of adverse maternal outcomes in the Republic of Georgia: a national birth registry-based cohort study

 

No confirmed SARS-CoV-2 infection (reference group)

n = 94,778*

Confirmed SARS-CoV-2 infection in early pregnancy*

n = 13,800*

Confirmed SARS-CoV-2 infection within 30 days before or at delivery

n = 2,915*

Maternal age, mean (SD)

28.9 (5.90)

29.6 (5.69)

29.4 (5.83)

Education, n (%)

   

 Primary

 Secondary

 Higher

 Unknown

7,395 (7.8)

38,869 (41.0)

29,922 (31.6)

18,591 (19.6)

441 (3.2)

5,227 (37.9)

5,221 (37.8)

2,911 (21.1)

163 (5.6)

1,161 (39.8)

995 (34.2)

594 (20.4)

Residency, n (%)

   

 Urban

 Rural

 Unknown

68,952 (72.8)

25,750 (27.1)

76 (0.1)

11,047 (80.0)

2,753 (20.0)

0 (0)

2,181 (74.9)

734 (25.1)

0 (0)

BMI at first ANC visit, n (%)

   

 <18.5

 18.5–24.9

 25–30

 >30

5,965 (6.6)

52,862 (58.5)

20,577 (22.8)

10,926 (12.1)

846 (6.3)

7,924 (58.8)

2,997 (22.3)

1,698 (12.6)

185 (6.6)

1,581 (56.3)

682 (24.3)

361 (12.8)

Parity, n (%)

   

 Primiparous

 Multiparous

36,508 (38.5)

58,270 (61.5)

5,621 (40.7)

8,179 (59.3)

1,166 (40.0)

1,749 (60.0)

Plurality, n (%)

   

 Singleton

 Multiple

93,167 (98.3)

1,611 (1.7)

13,585 (98.4)

215 (1.6)

2,865 (98.3)

50 (1.7)

Adherence to ANC**, n (%)

   

 No care

 Attended

4,400 (4.6)

90,378 (95.4)

313 (2.3)

13,487 (97.7)

85 (2.9)

2,830 (97.1)

Gestational age during first ANC visit, mean (SD)

10.1 (4.64)

9.8 (3.89)

9.6 (3.65)

Gestational diabetes, n (%)

   

 Yes

 No

143 (0.2)

94,634 (99.8)

31 (0.2)

13,769 (99.8)

7 (0.2)

2,906 (99.8)

Fully vaccinated***, n (%)

   

 Yes

 No

5,084 (5.4)

89,694 (94.6)

1,739 (12.6)

12,057 (87.4)

310 (10.6)

2,605 (89.4)

  1. * Not all numbers add up to the total because of missing observations in the Georgian Birth Registry
  2. ** Antenatal care
  3. *** Receiving two full doses of vaccine either before SARS-CoV-2 infection (for women with confirmed infection) or any time during pregnancy (for those with no confirmed infection)